Microparticle resins as a potential nasal drug delivery system for insulin

被引:24
|
作者
Takenaga, M [1 ]
Serizawa, Y [1 ]
Azechi, Y [1 ]
Ochiai, A [1 ]
Kosaka, Y [1 ]
Igarashi, R [1 ]
Mizushima, Y [1 ]
机构
[1] St Marianna Univ, Sch Med, Inst Med Sci, Div Drug Delivery Syst,Miyamae Ku, Kawasaki, Kanagawa 216, Japan
关键词
nasal administration; resins; insulin; rabbit; drug delivery;
D O I
10.1016/S0168-3659(97)00193-4
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The application of various resins for the nasal delivery of insulin was examined in rabbits, Intranasal administration of human insulin (28 U, 1 mg) mixed with fractionated sodium polystyrene sulfonate powder (an anionic resin with a particle size of 20-45 mu m) caused a rapid increase of the plasma insulin level to 413.0+/-71.7 mu U/ml (mean+/-S.D.) after 15 min, while intranasal administration of insulin alone caused little increase. The blood glucose level decreased from 118.8+/-18.5 mg/dl to 65.8+/-13.8 mg/dl at 45 min after administration. These results were superior to those obtained with the unfractionated resin, Styrene-divinylbenzene copolymer (a nonionic resin; 20-45 mu m fraction) showed similar enhancement of nasal insulin absorption. In contrast, polyacrylester (a nonionic resin; 20-45 mu m fraction) and cholestyramine (a cationic resin) did not promote insulin absorption. These results suggest that some resins may be useful for nasal delivery of insulin. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 50 条
  • [31] Progress in brain targeting drug delivery system by nasal route
    Khan, Abdur Rauf
    Liu, Mengrui
    Khan, Muhammad Wasim
    Zhai, Guangxi
    JOURNAL OF CONTROLLED RELEASE, 2017, 268 : 364 - 389
  • [32] Insoluble powder formulation as an effective nasal drug delivery system
    Ishikawa, F
    Murano, M
    Hiraishi, M
    Yamaguchi, T
    Tamai, I
    Tsuji, A
    PHARMACEUTICAL RESEARCH, 2002, 19 (08) : 1097 - 1104
  • [33] Nasal Drug Delivery System and Devices: An Overview on Health Effects
    Katare, Pratik
    Pawar Medhe, Tanvi
    Nadkarni, Akanksha
    Deshpande, Mrudul
    Tekade, Rakesh Kumar
    Benival, Derajram
    Jain, Aakanchha
    ACS CHEMICAL HEALTH & SAFETY, 2024, 31 (02) : 127 - 143
  • [34] Intranasal Insulin Delivery: Microparticle Formulations Consisting of Aloe vera Polysaccharides for Advanced Delivery across Excised Olfactory and Respiratory Nasal Epithelial Tissues
    Kirby-Smith, Cassandra
    Steenekamp, Jan
    Steyn, Dewald
    Haasbroek-Pheiffer, Anja
    Hamman, Hannlie
    Hamman, Josias
    APPLIED SCIENCES-BASEL, 2023, 13 (08):
  • [35] Nasal drug delivery - Preface
    Mitra, AK
    Harris, AS
    ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (1-2) : 1 - 1
  • [36] STUDIES ON NASAL DRUG DELIVERY
    DUCHATEAU, GSMJE
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (06) : 326 - 328
  • [37] Prodrugs in nasal drug delivery
    Tirucherai, GS
    Yang, C
    Mitra, AK
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (01) : 49 - 66
  • [38] In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan
    Krauland, Alexander H.
    Leitner, Verena M.
    Grabovac, Vjera
    Bernkop-Schnuerch, Andreas
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (11) : 2463 - 2472
  • [39] HYALURONIC-ACID ESTER MICROSPHERES AS A NASAL DELIVERY SYSTEM FOR INSULIN
    ILLUM, L
    FARRAJ, NF
    FISHER, AN
    GILL, I
    MIGLIETTA, M
    BENEDETTI, LM
    JOURNAL OF CONTROLLED RELEASE, 1994, 29 (1-2) : 133 - 141
  • [40] Cyclodextrins in nasal drug delivery
    Merkus, FWHM
    Verhoef, JC
    Marttin, E
    Romeijn, SG
    van der Kuy, PHM
    Hermens, WAJJ
    Schipper, NGM
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) : 41 - 57